Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

N Thalmann

Showing results (21-30 of 307) with videos related to

Pageof 31
Sort By:
BJU International|October 31, 2012
Comparative analysis of prostate-specific antigen free survival outcomes for patients with low, intermediate and high risk prostate cancer treatment by radical therapy. Results from the Prostate Cancer Results Study GroupPirus Ghadjar, George N Thalmann
Therapeutische Umschau. Revue Therapeutique|September 2, 2020
[Urologic Emergencies: Paraphimosis]Fabian P Stangl, George N Thalmann
BJU International|September 1, 2023
'Case of the Month' from the Universitaetsklinik für Urologie, Bern, Switzerland: management of an unusual foreign body in the renal pelvisKarl G Sommer, George N Thalmann
Nature Reviews. Urology|December 5, 2018
No survival benefit with extended lymphadenectomy: now what?Fiona C Burkhard, George N Thalmann
Nature Reviews. Urology|March 15, 2017
Contemporary update on neoadjuvant therapy for bladder cancerDaniel P Nguyen, George N Thalmann
BJU International|July 19, 2017
Sentinel nodes in prostate cancer- are we chasing a ghost?George N Thalmann, Daniel P Nguyen
Therapeutische Umschau. Revue Therapeutique|July 16, 2008
[Diagnosis, treatment and follow up of prostata cancer]Frédéric D Birkhäuser, George N Thalmann
BJU International|November 28, 2008
Outcomes of radical cystectomyGeorge N Thalmann, John P Stein
BJU International|September 11, 2020
Continent diversion: five decades of developments and evolutionFabian P Stangl, George N Thalmann
Der Urologe. Ausg. A|March 9, 2012
[Lymphadenectomy for bladder cancer: current status and controversies]T Metzger, G N Thalmann, P Zehnder
Pageof 31

Showing results (21-30 of 307) with videos related to

Sort By:
Pageof 31
BJU International|October 31, 2012
Comparative analysis of prostate-specific antigen free survival outcomes for patients with low, intermediate and high risk prostate cancer treatment by radical therapy. Results from the Prostate Cancer Results Study GroupPirus Ghadjar, George N Thalmann
Therapeutische Umschau. Revue Therapeutique|September 2, 2020
[Urologic Emergencies: Paraphimosis]Fabian P Stangl, George N Thalmann
BJU International|September 1, 2023
'Case of the Month' from the Universitaetsklinik für Urologie, Bern, Switzerland: management of an unusual foreign body in the renal pelvisKarl G Sommer, George N Thalmann
Nature Reviews. Urology|December 5, 2018
No survival benefit with extended lymphadenectomy: now what?Fiona C Burkhard, George N Thalmann
Nature Reviews. Urology|March 15, 2017
Contemporary update on neoadjuvant therapy for bladder cancerDaniel P Nguyen, George N Thalmann
BJU International|July 19, 2017
Sentinel nodes in prostate cancer- are we chasing a ghost?George N Thalmann, Daniel P Nguyen
Therapeutische Umschau. Revue Therapeutique|July 16, 2008
[Diagnosis, treatment and follow up of prostata cancer]Frédéric D Birkhäuser, George N Thalmann
BJU International|November 28, 2008
Outcomes of radical cystectomyGeorge N Thalmann, John P Stein
BJU International|September 11, 2020
Continent diversion: five decades of developments and evolutionFabian P Stangl, George N Thalmann
Der Urologe. Ausg. A|March 9, 2012
[Lymphadenectomy for bladder cancer: current status and controversies]T Metzger, G N Thalmann, P Zehnder
Pageof 31